“When researching this drug, if the patient is in severe viral intoxication, with (unhealthy) complexion, vegetative symptoms, that is, these are really toxic manifestations, after the first inhalation, the patient's condition changes, that is, we see clinical signs of a decrease viral load, ”TASS quotes her as saying.
She noted that the drug is intended for use only in hospitals so far, but it is planned to conduct a study to make it available in pharmacies for the treatment of outpatients.
On December 22, it became known that the Russian Ministry of Health has registered a drug for coronavirus infection "MIR 19".
It was developed on behalf of the head of the FMBA of Russia, Veronika Skvortsova, at the State Research Center Institute of Immunology.